The significant association of anti-Jo1 and anti-MDA-5 antibodies in our cohort is also in concordance with the established link between these autoantibodies and IIM phenotypes associated with ILD risk [1,5,6,7,25]. This evidence concerns the gene IFIH1 and interstitial lung disease.